Citation Impact
Citing Papers
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Gastric cancer
2016 Standout
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance
1997
Dasatinib
2009
Testicular Germ-Cell Cancer
1997 Standout
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia.
1994 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Sexual dimorphism in cancer
2016
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
αv Integrins as receptors for tumor targeting by circulating ligands
1997
Targeted treatments in colorectal cancer: state of the art and future perspectives
2010
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Colorectal cancer
2013 Standout
Sarcoidosis
2013 Standout
Mitochondria: In Sickness and in Health
2012 Standout
The single-cell transcriptional landscape of mammalian organogenesis
2019 StandoutNature
Cancer genes and the pathways they control
2004 Standout
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Conservation, Variability and the Modeling of Active Protein Kinases
2007 StandoutNobel
Polymer Therapeutics: Concepts and Applications
2006
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
1996
Chronic Myelogenous Leukemia
2002
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
1995
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials
2000
Sickle-cell disease
2010 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Gastric cancer
2020 Standout
Neuroblastoma
2007 Standout
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials
1999
Imatinib Mesylate — A New Oral Targeted Therapy
2002
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Chronic Myeloid Leukemia
1999
Chemotherapy of gastric cancer
1988
Congenital dyserythropoietic anaemia with novel intra‐erythroblastic and intra‐erythrocytic inclusions
1991
Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed
2003
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
1983 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy
1984
Clinical Studies with Modulators of Multidrug Resistance
1995
Gender Differences in UVB-Induced Skin Carcinogenesis, Inflammation, and DNA Damage
2007
Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction
2009
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
2010
Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
1999
Chemotherapy for advanced gastric cancer
2017 Standout
The Ultrastructure of Dyserythropoiesis in Aplastic Anaemia
1975
Nanoparticles in Photodynamic Therapy
2015 Standout
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
2011
Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
2013
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine
1999
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Bimonthly 24 h Infusion of High-Dose 5-Fluorouracil vs EAP Regimen in Patients with Advanced Gastric Cancer
2007
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
Impact of Metaiodobenzylguanidine Scintigraphy on Assessing Response of High-Risk Neuroblastoma to Dose-Intensive Induction Chemotherapy
2003
Expansion of the growth fraction in multiple myeloma with alkylating agents
1975
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia
2000
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Cannabinoids for Medical Use
2015 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Multiple Myeloma
2011 Standout
Requirement for TLR9 in the Immunomodulatory Activity of Propionibacterium acnes
2005
Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003
2007
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
2008
Polymere Therapeutika: Konzepte und Anwendungen
2006
The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells
1997
Oral bisphosphonates
2000
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
A systematic review of the role of bisphosphonates in metastatic disease
2004
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
CNS Metastases in Breast Cancer
2004
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of W. Queißer being referenced
Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer.
1986
Chemotherapy of Advanced Gastric Carcinoma
1986
Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*
2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies
2005
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score
1997
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
2000
Hepatotoxizität bei Etoposid-Ifosfamid-Kombinations-Chemotherapie
1988
High-Dose 5-Fluorouracil / Folinic Acid in Combination with Three-Weekly Mitomycin C in the Treatment of Advanced Gastric Cancer. A Phase II Study
2002
Oral Administration of Idarubicin as First Line Cytostatic Therapy in Patients with Metastasized Breast Cancer and Favourable Prognosis
1991
Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer
1993
Lobaplatin (D-19466) in Patients with Advanced Non-Small-Cell Lung Cancer: A Trial of the Association for Medical Oncology (AIO) Phase II Study Group
1996
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: A randomized study comparing different times and routes of administration of corynebacterium parvum
1984
Erythropoietic Cell Proliferation in Different Clinical States of <i>β</i>-Thalassaemia
1971
5-fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) for advanced gastric carcinoma. A phase II trial
1986
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
1999
Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study
1995
Characterization of Ineffective Erythropoiesis in Erythroleukaemia
1975
Behandlung von therapierefraktärem zytostatikainduzierten Erbrechen mit dem synthetischen Cannabinoid Levonantradol
1982
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
1993
Phase I Clinical Trial of Lobaplatin (D-19466) after Intravenous Bolus Injection
1994
Kombinierte autoradiographisch-cytophotometrische Untersuchungen von Keimzentrumszellen der menschlichen Tonsille
1969
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]
1994
Cytophotometrisch-autoradiographische Untersuchung der Zellproliferation bei paraprotein�mischen H�moblastosen mit leuk�mischen Blutbildver�nderungen
1973
Treatment of Relapsed Nonseminomatous Germ Cell Tumors with Vinorelbine: A Trial of the Phase 1/11 Study Group of the Association for Medical Oncology of the German Cancer Society
1993
Adjuvant 5-Fluorouracil and BCNU Chemotherapy in Gastric Cancer: 3-Year Results
1982
Proliferation Disturbances of Erythroblasts in Congenital Dyserythropoietic Anemia Type I and II
1971
Prospektive randomisierte Studie beim fortgeschrittenen Magenkarzinom: Vergleich der Kombination von 5-Fluorouracil und Carmustin ohne und mit Adriamycin
2008